Literature DB >> 25801184

A case report of osteomalacia unmasking primary biliary cirrhosis.

M Pawlowska1, J E Kapeluto, D L Kendler.   

Abstract

Osteomalacia, a metabolic bone disease characterized by the inability to mineralize new osteoid, can be caused by vitamin D deficiency. We report a patient with symptomatic, biochemical, and imaging evidence of osteomalacia due to vitamin D deficiency, who as a result of work up for bone disease was diagnosed with early primary biliary cirrhosis. Osteomalacia was treated with high-dose vitamin D and serial bone density scans showed evidence of increasing bone mineral density suggesting osteoid mineralization in response to treatment. The diagnosis of cholestatic liver disease should be considered in all patients presenting with osteomalacia due to vitamin D deficiency, particularly if other cholestatic liver enzymes are elevated in addition to alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801184     DOI: 10.1007/s00198-015-3102-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  12 in total

1.  Guidelines on the management of osteoporosis associated with chronic liver disease.

Authors:  Jane D Collier; M Ninkovic; J E Compston
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 2.  Clinical Review: The 2011 report on dietary reference intake for vitamin D: where do we go from here?

Authors:  John F Aloia
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

3.  Redefining vitamin D insufficiency.

Authors:  A Malabanan; I E Veronikis; M F Holick
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

4.  Changes in bone mineral density following treatment of osteomalacia.

Authors:  Rajiv Bhambri; Vaishali Naik; Nidhi Malhotra; Shilpa Taneja; Saurabh Rastogi; Uma Ravishanker; Ambrish Mithal
Journal:  J Clin Densitom       Date:  2006-03-27       Impact factor: 2.617

5.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

6.  Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.

Authors:  Núria Guañabens; Albert Parés; Inmaculada Ros; Llorenç Caballería; Francesca Pons; Sergi Vidal; Ana Monegal; Pilar Peris; Juan Rodés
Journal:  J Hepatol       Date:  2005-01-13       Impact factor: 25.083

Review 7.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

Authors:  P Lips
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

8.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

9.  Noninvasive testing in the diagnosis of osteomalacia.

Authors:  C T Bingham; L A Fitzpatrick
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

10.  Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

Authors:  K D Lindor; C H Janes; J S Crippin; R A Jorgensen; E R Dickson
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.